Paraneoplastic Cushing's syndrome as the first sign of progression of prostate cancer.
Cushing's syndrome accompanying the small cell de-differentiation of the prostatic adenocarcinoma is a relatively rare clinical entity, associated with poor overall prognosis. Despite several treatment options available, there is still no effective standard therapy for this clinical condition. Herein, we report two patients with prostate cancer presenting with clinical and laboratory features of Cushing's syndrome as the first sign of disease progression (Ref. 4). Full Text (Free, PDF) www.bmj.sk.
Department of Medical Oncology, School of Medicine, Comenius University, Bratislava, Slovakia. jan.rajec@fmed.uniba.sk
J
J
Rajec
M
M
Mego
Z
Z
Sycova-Mila
J
J
Obertova
K
K
Brozmanova
J
J
Mardiak
D000230:Adenocarcinoma / Q000150:complications* / Q000628:therapy; D000368:Aged; D003480:Cushing Syndrome / Q000150:complications* / Q000175:diagnosis / Q000628:therapy; D018450:Disease Progression; D006801:Humans; D008297:Male; D008875:Middle Aged; D009384:Paraneoplastic Endocrine Syndromes / Q000150:complications* / Q000175:diagnosis / Q000628:therapy; D011471:Prostatic Neoplasms / Q000150:complications* / Q000628:therapy